PMID- 35091032
OWN - NLM
STAT- MEDLINE
DCOM- 20220706
LR  - 20220804
IS  - 1532-8406 (Electronic)
IS  - 0883-5403 (Linking)
VI  - 37
IP  - 8S
DP  - 2022 Aug
TI  - Minimal Clinically Important Difference (MCID) at One Year Postoperatively in 
      Aseptic Revision Total Hip Arthroplasty.
PG  - S954-S957
LID - S0883-5403(22)00061-4 [pii]
LID - 10.1016/j.arth.2022.01.044 [doi]
AB  - BACKGROUND: Outcomes after aseptic revision total hip arthroplasty (THA) are 
      variable, and it is unknown whether the indication for aseptic revision THA 
      influences postoperative clinical improvement. The minimal clinically important 
      difference (MCID) assesses if changes in patient-reported outcome measure result 
      in meaningful clinical benefit to patients. The purpose of this study was to 
      quantify the 1-year postoperative MCID for aseptic revision THA and to assess the 
      percentage of patients achieving the MCID for each revision diagnosis. METHODS: A 
      prospective, single-institution registry of revision total joint arthroplasties 
      was used. Retrospective review of 413 first-time aseptic revision THAs was 
      performed. Demographics, revision diagnosis, preoperative Hip Disability and 
      Osteoarthritis Outcome Score, Joint Replacement (HOOS Jr.), and 1-year 
      postoperative HOOS Jr. were recorded. The MCID for the HOOS Jr. at one year 
      postoperatively was calculated for each revision diagnosis using a 
      distribution-based method. The percentage of patients exceeding the MCID with 
      each diagnosis was determined. RESULTS: There were 9 aseptic revision diagnoses, 
      all with n >/= 5. The 3 most common revision diagnosis were aseptic loosening (n = 
      114), dislocation or instability (n = 103), and polyethylene wear or osteolysis 
      (n = 73). The MCID for all the aseptic revision THAs was 10.9. Seven of the nine 
      revision diagnoses achieved the MCID. The highest percentage of patients 
      achieving the MCID was for aseptic loosening (84.2%) and implant fracture 
      (81.3%), whereas lowest was for adverse local tissue reaction (35.3%) and implant 
      recall (20.0%). CONCLUSION: The one-year revision THA MCID is 10.9 for the HOOS 
      Jr. There is variability in the percentage of patients achieving the MCID based 
      on diagnosis. Our data can be used to counsel patients undergoing revision THA 
      for noninfectious etiologies.
CI  - Copyright (c) 2022 Elsevier Inc. All rights reserved.
FAU - Bendich, Ilya
AU  - Bendich I
AD  - Division of Adult Reconstruction and Joint Replacement, Hospital for Special 
      Surgery, New York, NY.
FAU - Tarity, Thomas D
AU  - Tarity TD
AD  - Division of Adult Reconstruction and Joint Replacement, Hospital for Special 
      Surgery, New York, NY.
FAU - Alpaugh, Kyle
AU  - Alpaugh K
AD  - Division of Adult Reconstruction and Joint Replacement, Hospital for Special 
      Surgery, New York, NY.
FAU - Lyman, Stephen
AU  - Lyman S
AD  - Division of Adult Reconstruction and Joint Replacement, Hospital for Special 
      Surgery, New York, NY.
FAU - Sculco, Peter K
AU  - Sculco PK
AD  - Division of Adult Reconstruction and Joint Replacement, Hospital for Special 
      Surgery, New York, NY.
FAU - McLawhorn, Alexander S
AU  - McLawhorn AS
AD  - Division of Adult Reconstruction and Joint Replacement, Hospital for Special 
      Surgery, New York, NY.
LA  - eng
PT  - Journal Article
DEP - 20220126
PL  - United States
TA  - J Arthroplasty
JT  - The Journal of arthroplasty
JID - 8703515
SB  - IM
MH  - *Arthroplasty, Replacement, Hip/adverse effects
MH  - *Hip Prosthesis/adverse effects
MH  - Humans
MH  - Minimal Clinically Important Difference
MH  - Prospective Studies
MH  - Prosthesis Failure
MH  - Reoperation
MH  - Retrospective Studies
MH  - Treatment Outcome
OTO - NOTNLM
OT  - aseptic loosening
OT  - dislocation
OT  - outcomes
OT  - patient-reported outcome (PROM)
OT  - revision hip arthroplasty
EDAT- 2022/01/30 06:00
MHDA- 2022/07/07 06:00
CRDT- 2022/01/29 05:35
PHST- 2021/12/03 00:00 [received]
PHST- 2022/01/20 00:00 [accepted]
PHST- 2022/01/30 06:00 [pubmed]
PHST- 2022/07/07 06:00 [medline]
PHST- 2022/01/29 05:35 [entrez]
AID - S0883-5403(22)00061-4 [pii]
AID - 10.1016/j.arth.2022.01.044 [doi]
PST - ppublish
SO  - J Arthroplasty. 2022 Aug;37(8S):S954-S957. doi: 10.1016/j.arth.2022.01.044. Epub 
      2022 Jan 26.